We provide specialized drug product development for pediatric and geriatric populations. We offer a full range of multiparticulate technologies, as well as chewable and orally disintegrating tablet options and expertise in taste and odor masking.
Lipid Multiparticulates are highly flexible to meet target product profiles and formulation requirements and are often the most suitable approach to design drug products for these populations.
Develop Viable Tablet Formulations
We take a rational design approach in developing viable formulations. When immature swallowing function limits the choice of dosage form, tablets can offer the solution.
Experts in Taste and Odor Masking
We have utilized our drug design and formulation expertise to develop an array of effective taste-masking approaches which have been shown to have a marked effect on patient compliance.
Our approach for pediatric and geriatric applications
Our product development teams understand the challenges in defining problem statements and developing formulation strategies for pediatric and geriatric applications:
Physiology, pharmacology and toxicology can differ
Swallowing function limits the choice of dosage form
Disease patterns and trajectories can differ
Individualized dosing regimens, by age, bodyweight, etc., are required
Taste, odor and palatability must be acceptable to facilitate the administration
Excipients restricted to those with proven safety in pediatric patients with limited/immature ADME
Our rational design approach
We take a rational design approach in developing viable formulations for specialized populations.
We have found that multiparticulate (MP) technologies can typically meet the diverse requirements of specialized patient therapies. MP approaches are highly flexible in terms of meeting target product profiles and formulation requirements and are frequently the most appropriate approach for designing drug products for specialized patient populations.
When oral solid dosing is preferred, the final choice between orally dissolving tablets, tablets and MP technology is based on multiple factors. These iclude dose loading required, the spectrum of pediatric and geriatric patients targeted, the degree of taste or odor masking needed and commercial objectives.
Benefit from our extensive experience with a range of proven enabling technologies, many of which have been developed or advanced by our teams:
solid dispersions
multiparticulates
particle size reduction
fixed-dose combinations
engineered particles for inhaled applications
modified- and targeted-release formulations
sterile fill and finish for parenteral applications
Our locations
Global, high-quality facilities that bring your molecule to life